Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Karen, Leavens"'
Autor:
Christopher J. Delves, Caroline O. S. Savage, Tim S. Schmidt, Lea Fortunato, Emilie Charles, Thomas Matthew Webb, Lia Liefaard, Nicolas Wisniacki, John Stone, Rainard Fuhr, Sara Brett, Stephen A. Hughes, Ruth M. Tarzi, Muna Albayaty, Christine Barrett, Ken Edwards, Karen Leavens, Katherine Nevin, Rabia Anselm, Joanne Ellis, Shuo Tang, Martin Coenen, T.G. Hopkins, N Srinivasan, Yi Cui, Daniel J.B. Marks, Anna Richards, Maria Feeney
Publikováno v:
Clinical Pharmacology & Therapeutics. 109:1293-1303
Activated T cells drive a range of immune-mediated inflammatory diseases. LAG-3 is transiently expressed on recently activated CD4+ and CD8+ T cells. We describe the engineering and first-in-human clinical study (NCT02195349) of GSK2831781 (an afucos
Autor:
Karen Leavens, Lucy C. Garner, Stephen A. Hughes, Kevin R. Page, D Krull, Stephanie Slevin, Kate D. Lynch, Ruth M. Tarzi, Carolina V. Arancibia-Cárcamo, Malcolm Tan, Conor Lahiff, B Greenaway, Katherine Nevin, Simon Travis, Helen Ferry, Alessandra Geremia, Lai Mun Wang, Satish Keshav, Marks Djb., Paul Klenerman, N Srinivasan
Publikováno v:
Journal of Crohn's & Colitis
Background and Aims Lymphocyte activation gene [LAG]-3 is an immune checkpoint and its expression identifies recently activated lymphocytes that may contribute to inflammation. We investigated the role of LAG-3 by analysing its expression and functio
Autor:
Joanne, Ellis, Daniel, J B Marks, Naren, Srinivasan, Christine, Barrett, Thomas G, Hopkins, Anna, Richards, Rainard, Fuhr, Muna, Albayaty, Martin, Coenen, Lia, Liefaard, Karen, Leavens, Katherine L, Nevin, Shuo, Tang, Stephen A, Hughes, Léa, Fortunato, Ken, Edwards, Yi, Cui, Rabia, Anselm, Christopher J, Delves, Emilie, Charles, Maria, Feeney, Thomas M, Webb, Sara J, Brett, Tim S, Schmidt, John, Stone, Caroline O S, Savage, Nicolas, Wisniacki, Ruth M, Tarzi
Publikováno v:
Clinical Pharmacology and Therapeutics
Activated T cells drive a range of immune‐mediated inflammatory diseases. LAG‐3 is transiently expressed on recently activated CD4+ and CD8+ T cells. We describe the engineering and first‐in‐human clinical study (NCT02195349) of GSK2831781 (a
Autor:
Ruth M. Tarzi, B Greenaway, Marks Djb., Stephen A. Hughes, Katherine Nevin, S Slevin, Kate D. Lynch, M Tan, N Srinivasan, Simon Travis, Conor Lahiff, Satish Keshav, Karen Leavens, Alessandra Geremia, Lai Mun Wang, C Arancibia
Publikováno v:
Journal of Crohn's and Colitis. 13:S033-S033
Autor:
Katherine Nevin, Karen Leavens, D Marks, Martin Coenen, J Stone, R Anselm, Anna Richards, Lia Liefaard, Stephen A. Hughes, N Srinivasan, Ruth M. Tarzi, Tim S. Schmidt, Rainard Fuhr, Nicolas Wisniacki, Muna Albayaty, Christine Barrett, Ken Edwards, T.G. Hopkins, S Tang, Joanne Ellis, Caroline O. S. Savage
Publikováno v:
Journal of Crohn's and Colitis. 13:S336-S336
Autor:
Deborah Needham, Jason A. Holt, Stuart N. Farrow, Robert J. H. Austin, Keith Biggadike, Karen Leavens, Iain Uings, Davina C. Angell, Michael V. Haase, Joyce Lesley Matthews
Publikováno v:
British Journal of Pharmacology. 169:1389-1403
Background and Purpose Glucocorticoids are highly effective therapies for a range of inflammatory diseases. Advances in the understanding of the diverse molecular mechanisms underpinning glucocorticoid action suggest that anti-inflammatory molecules
Autor:
Nigel Deeks, Karen Leavens, Aarti Patel, Colin A. Campbell, Helen Garden, Jenni Cryan, Emmanuel Hubert Demont, Simon Taylor, Jason Witherington, Pam Gaskin, Andrea C. Haynes, Simon J. Dowell, Robert Willis, James Gray, Mary A. Morse
Publikováno v:
Xenobiotica. 42:671-686
Sphingosine-1-phosphate (S1P(1)) receptor agonists such as Fingolimod (FTY-720) are a novel class of immunomodulators that have clinical utility in the treatment of remitting relapsing multiples sclerosis. This class of compound act by inducing perip
Autor:
Philip Alan Skone, Donald O. Somers, Marion C. Dickson, Nick Smithers, Ann Louise Walker, Thomas George Christopher Hayhow, Stuart G. Leach, Karen Leavens, Clement Douault, Emma J. Jones, Dorothy Elwes, Robert J. Watson, Margarete Neu, Robert P. Davis, Matthew Gray, Neil Stuart Garton, Clare I. Hobbs, Alex Preston, Michael David Barker, Vipulkumar Kantibhai Patel, Cesar Ramirez-Molina, Paul S. Carter, Scott McCleary, Gordon G. Weingarten, Huw D. Lewis, Francis Louis Atkinson, John Liddle, Tracy Jane Shipley, Neil R. Curtis
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:6188-6194
The lead optimisation of the diaminopyrimidine carboxamide series of spleen tyrosine kinase inhibitors is described. The medicinal chemistry strategy was focused on optimising the human whole blood activity whilst achieving a sufficient margin over l
Autor:
Slevin, Stephanie M1 (AUTHOR) carolina.arancibia@ndm.ox.ac.uk, Garner, Lucy C1 (AUTHOR), Lahiff, Conor1 (AUTHOR), Tan, Malcolm1 (AUTHOR), Wang, Lai Mun2 (AUTHOR), Ferry, Helen1 (AUTHOR), Greenaway, Borgel1 (AUTHOR), Lynch, Kate1 (AUTHOR), Geremia, Alessandra1 (AUTHOR), Hughes, Stephen3 (AUTHOR), Leavens, Karen3 (AUTHOR), Krull, David4 (AUTHOR), Marks, Daniel J B3 (AUTHOR), Nevin, Katherine3 (AUTHOR), Page, Kevin3 (AUTHOR), Srinivasan, Naren3 (AUTHOR), Tarzi, Ruth3 (AUTHOR), Klenerman, Paul1,5 (AUTHOR), Travis, Simon1 (AUTHOR), Arancibia-Cárcamo, Carolina V1 (AUTHOR) carolina.arancibia@ndm.ox.ac.uk
Publikováno v:
Journal of Crohn's & Colitis. Oct2020, Vol. 14 Issue 10, p1446-1461. 16p.
Autor:
Taylor, Simon1 (AUTHOR) Simon.5.taylor@gsk.com, Gray, James R. J.1 (AUTHOR), Willis, Robert1 (AUTHOR), Deeks, Nigel1 (AUTHOR), Haynes, Andrea1 (AUTHOR), Campbell, Colin1 (AUTHOR), Gaskin, Pam1 (AUTHOR), Leavens, Karen1 (AUTHOR), Demont, Emmanuel1 (AUTHOR), Dowell, Simon2 (AUTHOR), Cryan, Jenni2 (AUTHOR), Morse, Mary1 (AUTHOR), Patel, Aarti3 (AUTHOR), Garden, Helen4 (AUTHOR), Witherington, Jason1 (AUTHOR)
Publikováno v:
Xenobiotica. Jul2012, Vol. 42 Issue 7, p671-686. 16p. 1 Diagram, 4 Charts, 8 Graphs.